Article Details
Retrieved on: 2018-03-06 05:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>CAMBRIDGE, Mass.--(Business Wire)--Goldfinch Bio, a company singularly focused on discovering and developing precision therapies to treat patients with kidney disease, today announced that Anthony Johnson, M.D., president and chief executive officer, will present a corporate overview at the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here